PMC:7105881 / 30936-31568 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T155","span":{"begin":23,"end":31},"obj":"Body_part"},{"id":"T156","span":{"begin":108,"end":113},"obj":"Body_part"},{"id":"T157","span":{"begin":120,"end":128},"obj":"Body_part"},{"id":"T158","span":{"begin":139,"end":146},"obj":"Body_part"},{"id":"T159","span":{"begin":213,"end":217},"obj":"Body_part"},{"id":"T160","span":{"begin":219,"end":232},"obj":"Body_part"},{"id":"T161","span":{"begin":219,"end":230},"obj":"Body_part"},{"id":"T162","span":{"begin":240,"end":253},"obj":"Body_part"},{"id":"T163","span":{"begin":240,"end":251},"obj":"Body_part"},{"id":"T164","span":{"begin":262,"end":276},"obj":"Body_part"},{"id":"T165","span":{"begin":262,"end":273},"obj":"Body_part"},{"id":"T166","span":{"begin":385,"end":390},"obj":"Body_part"},{"id":"T167","span":{"begin":601,"end":607},"obj":"Body_part"}],"attributes":[{"id":"A155","pred":"fma_id","subj":"T155","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A156","pred":"fma_id","subj":"T156","obj":"http://purl.org/sig/ont/fma/fma7209"},{"id":"A157","pred":"fma_id","subj":"T157","obj":"http://purl.org/sig/ont/fma/fma82751"},{"id":"A158","pred":"fma_id","subj":"T158","obj":"http://purl.org/sig/ont/fma/fma82775"},{"id":"A159","pred":"fma_id","subj":"T159","obj":"http://purl.org/sig/ont/fma/fma84051"},{"id":"A160","pred":"fma_id","subj":"T160","obj":"http://purl.org/sig/ont/fma/fma84051"},{"id":"A161","pred":"fma_id","subj":"T161","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A162","pred":"fma_id","subj":"T162","obj":"http://purl.org/sig/ont/fma/fma264831"},{"id":"A163","pred":"fma_id","subj":"T163","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A164","pred":"fma_id","subj":"T164","obj":"http://purl.org/sig/ont/fma/fma264825"},{"id":"A165","pred":"fma_id","subj":"T165","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A166","pred":"fma_id","subj":"T166","obj":"http://purl.org/sig/ont/fma/fma67264"},{"id":"A167","pred":"fma_id","subj":"T167","obj":"http://purl.org/sig/ont/fma/fma9637"}],"text":"aAbs, antibodies; ADE, antibody-dependent enhancement; Alum hydro, aluminum hydroxide; CHO, Chinese hamster ovary; CpG, cysteine-phosphate-guanine; I.D., intradermal; I.M., intramuscular; IFN-γ, interferon gamma; IL-2, interleukin 2; IL-4, interleukin 4; IL-10, Interleukin 10; I.P., intraperitoneal; mAbs, monoclonal antibodies; Montanide, Montanide ISA-51; MPL + TDM, monophosphoryl lipid A and trehalose dicorynomycolate; N/A, not reported; NTD, N-terminal domain; NZW rabbits, New Zealand White rabbits; RBD, receptor-binding domain; SAS, Sigma adjuvant system; S.C., subcutaneous; TCID50, median tissue culture infectious dose."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T12","span":{"begin":601,"end":607},"obj":"Body_part"}],"attributes":[{"id":"A12","pred":"uberon_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/UBERON_0000479"}],"text":"aAbs, antibodies; ADE, antibody-dependent enhancement; Alum hydro, aluminum hydroxide; CHO, Chinese hamster ovary; CpG, cysteine-phosphate-guanine; I.D., intradermal; I.M., intramuscular; IFN-γ, interferon gamma; IL-2, interleukin 2; IL-4, interleukin 4; IL-10, Interleukin 10; I.P., intraperitoneal; mAbs, monoclonal antibodies; Montanide, Montanide ISA-51; MPL + TDM, monophosphoryl lipid A and trehalose dicorynomycolate; N/A, not reported; NTD, N-terminal domain; NZW rabbits, New Zealand White rabbits; RBD, receptor-binding domain; SAS, Sigma adjuvant system; S.C., subcutaneous; TCID50, median tissue culture infectious dose."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T155","span":{"begin":18,"end":21},"obj":"Disease"},{"id":"T156","span":{"begin":444,"end":447},"obj":"Disease"},{"id":"T158","span":{"begin":616,"end":626},"obj":"Disease"}],"attributes":[{"id":"A155","pred":"mondo_id","subj":"T155","obj":"http://purl.obolibrary.org/obo/MONDO_0019383"},{"id":"A156","pred":"mondo_id","subj":"T156","obj":"http://purl.obolibrary.org/obo/MONDO_0008449"},{"id":"A157","pred":"mondo_id","subj":"T156","obj":"http://purl.obolibrary.org/obo/MONDO_0018075"},{"id":"A158","pred":"mondo_id","subj":"T158","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"aAbs, antibodies; ADE, antibody-dependent enhancement; Alum hydro, aluminum hydroxide; CHO, Chinese hamster ovary; CpG, cysteine-phosphate-guanine; I.D., intradermal; I.M., intramuscular; IFN-γ, interferon gamma; IL-2, interleukin 2; IL-4, interleukin 4; IL-10, Interleukin 10; I.P., intraperitoneal; mAbs, monoclonal antibodies; Montanide, Montanide ISA-51; MPL + TDM, monophosphoryl lipid A and trehalose dicorynomycolate; N/A, not reported; NTD, N-terminal domain; NZW rabbits, New Zealand White rabbits; RBD, receptor-binding domain; SAS, Sigma adjuvant system; S.C., subcutaneous; TCID50, median tissue culture infectious dose."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T401","span":{"begin":87,"end":90},"obj":"http://purl.obolibrary.org/obo/CLO_0002421"},{"id":"T402","span":{"begin":87,"end":90},"obj":"http://purl.obolibrary.org/obo/CLO_0052479"},{"id":"T403","span":{"begin":87,"end":90},"obj":"http://purl.obolibrary.org/obo/CLO_0052480"},{"id":"T404","span":{"begin":87,"end":90},"obj":"http://purl.obolibrary.org/obo/CLO_0052483"},{"id":"T405","span":{"begin":87,"end":90},"obj":"http://purl.obolibrary.org/obo/CLO_0052484"},{"id":"T406","span":{"begin":87,"end":90},"obj":"http://purl.obolibrary.org/obo/CLO_0052485"},{"id":"T407","span":{"begin":100,"end":107},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10026"},{"id":"T408","span":{"begin":108,"end":113},"obj":"http://www.ebi.ac.uk/efo/EFO_0000973"},{"id":"T409","span":{"begin":195,"end":211},"obj":"http://purl.obolibrary.org/obo/PR_000000017"},{"id":"T410","span":{"begin":213,"end":217},"obj":"http://purl.obolibrary.org/obo/PR_000001379"},{"id":"T411","span":{"begin":219,"end":232},"obj":"http://purl.obolibrary.org/obo/PR_000001379"},{"id":"T412","span":{"begin":262,"end":276},"obj":"http://purl.obolibrary.org/obo/PR_000001471"},{"id":"T413","span":{"begin":391,"end":392},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T414","span":{"begin":427,"end":428},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T415","span":{"begin":538,"end":541},"obj":"http://purl.obolibrary.org/obo/CLO_0051568"}],"text":"aAbs, antibodies; ADE, antibody-dependent enhancement; Alum hydro, aluminum hydroxide; CHO, Chinese hamster ovary; CpG, cysteine-phosphate-guanine; I.D., intradermal; I.M., intramuscular; IFN-γ, interferon gamma; IL-2, interleukin 2; IL-4, interleukin 4; IL-10, Interleukin 10; I.P., intraperitoneal; mAbs, monoclonal antibodies; Montanide, Montanide ISA-51; MPL + TDM, monophosphoryl lipid A and trehalose dicorynomycolate; N/A, not reported; NTD, N-terminal domain; NZW rabbits, New Zealand White rabbits; RBD, receptor-binding domain; SAS, Sigma adjuvant system; S.C., subcutaneous; TCID50, median tissue culture infectious dose."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T161","span":{"begin":67,"end":75},"obj":"Chemical"},{"id":"T162","span":{"begin":76,"end":85},"obj":"Chemical"},{"id":"T163","span":{"begin":120,"end":128},"obj":"Chemical"},{"id":"T164","span":{"begin":129,"end":138},"obj":"Chemical"},{"id":"T168","span":{"begin":139,"end":146},"obj":"Chemical"},{"id":"T169","span":{"begin":195,"end":205},"obj":"Chemical"},{"id":"T170","span":{"begin":206,"end":211},"obj":"Chemical"},{"id":"T171","span":{"begin":213,"end":215},"obj":"Chemical"},{"id":"T173","span":{"begin":234,"end":236},"obj":"Chemical"},{"id":"T175","span":{"begin":255,"end":257},"obj":"Chemical"},{"id":"T177","span":{"begin":385,"end":392},"obj":"Chemical"},{"id":"T180","span":{"begin":385,"end":390},"obj":"Chemical"},{"id":"T181","span":{"begin":397,"end":406},"obj":"Chemical"},{"id":"T182","span":{"begin":549,"end":557},"obj":"Chemical"}],"attributes":[{"id":"A161","pred":"chebi_id","subj":"T161","obj":"http://purl.obolibrary.org/obo/CHEBI_28984"},{"id":"A162","pred":"chebi_id","subj":"T162","obj":"http://purl.obolibrary.org/obo/CHEBI_16234"},{"id":"A163","pred":"chebi_id","subj":"T163","obj":"http://purl.obolibrary.org/obo/CHEBI_15356"},{"id":"A164","pred":"chebi_id","subj":"T164","obj":"http://purl.obolibrary.org/obo/CHEBI_18367"},{"id":"A165","pred":"chebi_id","subj":"T164","obj":"http://purl.obolibrary.org/obo/CHEBI_26020"},{"id":"A166","pred":"chebi_id","subj":"T164","obj":"http://purl.obolibrary.org/obo/CHEBI_35780"},{"id":"A167","pred":"chebi_id","subj":"T164","obj":"http://purl.obolibrary.org/obo/CHEBI_43474"},{"id":"A168","pred":"chebi_id","subj":"T168","obj":"http://purl.obolibrary.org/obo/CHEBI_16235"},{"id":"A169","pred":"chebi_id","subj":"T169","obj":"http://purl.obolibrary.org/obo/CHEBI_52999"},{"id":"A170","pred":"chebi_id","subj":"T170","obj":"http://purl.obolibrary.org/obo/CHEBI_30212"},{"id":"A171","pred":"chebi_id","subj":"T171","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A172","pred":"chebi_id","subj":"T171","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A173","pred":"chebi_id","subj":"T173","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A174","pred":"chebi_id","subj":"T173","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A175","pred":"chebi_id","subj":"T175","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A176","pred":"chebi_id","subj":"T175","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A177","pred":"chebi_id","subj":"T177","obj":"http://purl.obolibrary.org/obo/CHEBI_25051"},{"id":"A178","pred":"chebi_id","subj":"T177","obj":"http://purl.obolibrary.org/obo/CHEBI_47040"},{"id":"A179","pred":"chebi_id","subj":"T177","obj":"http://purl.obolibrary.org/obo/CHEBI_58712"},{"id":"A180","pred":"chebi_id","subj":"T180","obj":"http://purl.obolibrary.org/obo/CHEBI_18059"},{"id":"A181","pred":"chebi_id","subj":"T181","obj":"http://purl.obolibrary.org/obo/CHEBI_27082"},{"id":"A182","pred":"chebi_id","subj":"T182","obj":"http://purl.obolibrary.org/obo/CHEBI_60809"}],"text":"aAbs, antibodies; ADE, antibody-dependent enhancement; Alum hydro, aluminum hydroxide; CHO, Chinese hamster ovary; CpG, cysteine-phosphate-guanine; I.D., intradermal; I.M., intramuscular; IFN-γ, interferon gamma; IL-2, interleukin 2; IL-4, interleukin 4; IL-10, Interleukin 10; I.P., intraperitoneal; mAbs, monoclonal antibodies; Montanide, Montanide ISA-51; MPL + TDM, monophosphoryl lipid A and trehalose dicorynomycolate; N/A, not reported; NTD, N-terminal domain; NZW rabbits, New Zealand White rabbits; RBD, receptor-binding domain; SAS, Sigma adjuvant system; S.C., subcutaneous; TCID50, median tissue culture infectious dose."}

{"project":"LitCovid-sentences","denotations":[{"id":"T190","span":{"begin":0,"end":632},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"aAbs, antibodies; ADE, antibody-dependent enhancement; Alum hydro, aluminum hydroxide; CHO, Chinese hamster ovary; CpG, cysteine-phosphate-guanine; I.D., intradermal; I.M., intramuscular; IFN-γ, interferon gamma; IL-2, interleukin 2; IL-4, interleukin 4; IL-10, Interleukin 10; I.P., intraperitoneal; mAbs, monoclonal antibodies; Montanide, Montanide ISA-51; MPL + TDM, monophosphoryl lipid A and trehalose dicorynomycolate; N/A, not reported; NTD, N-terminal domain; NZW rabbits, New Zealand White rabbits; RBD, receptor-binding domain; SAS, Sigma adjuvant system; S.C., subcutaneous; TCID50, median tissue culture infectious dose."}